Eversept Partners LP Takes $32.55 Million Position in Healthpeak Properties, Inc. $DOC

Eversept Partners LP bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the first quarter, HoldingsChannel.com reports. The fund bought 1,981,070 shares of the real estate investment trust’s stock, valued at approximately $32,549,000. Healthpeak Properties comprises 1.7% of Eversept Partners LP’s investment portfolio, making the stock its 15th largest position.

Other hedge funds have also recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC lifted its stake in Healthpeak Properties by 7.3% during the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after purchasing an additional 63,930 shares in the last quarter. Woodline Partners LP grew its stake in shares of Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after purchasing an additional 17,279 shares during the period. Brown Advisory Inc. grew its stake in shares of Healthpeak Properties by 3.1% in the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after purchasing an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Healthpeak Properties in the 2nd quarter worth approximately $3,117,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $22.53 on Tuesday. The stock has a 50-day simple moving average of $20.80 and a 200 day simple moving average of $18.51. The stock has a market capitalization of $15.53 billion, a price-to-earnings ratio of 70.41, a P/E/G ratio of 3.46 and a beta of 1.02. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.77.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the prior year, the firm earned $0.46 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.23% of the company’s stock.

Analysts Set New Price Targets

DOC has been the subject of several analyst reports. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Wells Fargo & Company increased their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. Raymond James Financial began coverage on shares of Healthpeak Properties in a research note on Wednesday, June 17th. They issued a “market perform” rating on the stock. Barclays assumed coverage on shares of Healthpeak Properties in a report on Tuesday, July 7th. They issued an “equal weight” rating and a $23.00 target price on the stock. Finally, Morgan Stanley reissued an “equal weight” rating and set a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Four research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.62.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.